The Next Generation of Healthcare
Faith-Based Communities Stepping in to Address Opioid Epidemic
NBC says "I'm In" to Combat COVID-19 with ProIV and EcoHealth
Check out our ProIV treatment
Non-opiod, non-addictive, 97% natural treatment for pain management
Our Solutions
OWVI-19 is the first of 5 pharmacological solutions for submission to the US Food & Drug Administration to directly combat COVID-19. We will demonstrate, our turnkey green business model will also save taxpayers billions. Our comprehensive community health continuum addresses not only the current pandemic, but future pandemics. The brown community remains in a state of emergency as COVID-19 persists in these underserved communities. This investigation will include 30,000+ patients from the National Baptist Convention led by the I’m In Corporation and general community, with oversight from Quantum Health Discoveries Research Institute.
-19
OWVI-19 Immune Support
Objective: Research supports 90% of the US is micronutrient deficient. Our fundamental approach is to raise the base level of patients in the trial as we call it “priming” the patient. There is strong data to support the role each element plays. This, coupled with intravenous administration, our therapeutic provides a viable alternative therapy for those averse to vaccination. Additionally, we believe OWVI-19 will be of benefit for prevention, in-crisis and post COVID recovery.
vax
OWVI Vax Nasal Solution
OWVIVAX is the first intranasal vaccine which is a prophylactic that provides protection against Covid-19 infections, including the emerging variant strains. The nasal administered spray delivers multiple human IgG antibodies with complementary neutralizing epitopes that efficiently neutralize all 41 RBD variants of the SARS CoV2 viruses tested, including the UK and South African strains. The product is formulated with a proprietary chitosan ingredient providing prolonged resonance time for the protective antibodies in the nasal mucosa. Dioguard provides an effective barrier for protection against Covid-19 infections for up to 12 hours.
-19b
OWVI-19b Nasal Blower
OWVI-19 - B is powered by a proprietary device which will blow a reformulated powdered solution into the nasal cavity. This will be the most common application of the OWVI-19 Immune Support.
mins
OWVI Oral Minerals
OWVIMINS are organic supplements which plays a complementary role to OWVI-19 AND OWVIVAX. Data supports effectiveness with COVID-19 and Flu patients. Traditionally, the FDA does not grant Vitamins drug indications and true drug indication is important because it will allow for greater acceptance with AMA and NMA members who are averse to “alternative” adjunctive treatments. All citizens should have access to FREE oral support. As with vaccination, in partnership with UPS, all citizens should be able to have access via mail to receive free immune support. This is a cost effective countermeasure for individuals averse to vaccination.
vaxb
OWVI Vaxb Nasal Blower
OWVIVAX- B is powered by a proprietary device which will blow a reformulated powdered solution into the nasal cavity.
Mycol Discoveries LLC, led by Alan Attridge and OWVI, Inc. led by Jamie Dukes are pleased to present this synopsis of both the philosophical alignment of their respective business visions and their mutual understanding/agreement of how to leverage their respective expertise, contacts, and assets to fulfill those visions.
OWVI, Inc. is in the business of the manufacturing and distribution of micro-nutrient therapeutics and mobile healthcare deployment services. Mycol Discoveries, LLC, in combination with Quantum Health Discoveries Research Institute, is in the business of researching the health supporting features of medicinal mushrooms, creating unique formulas, and growing the various species of mushrooms to meet expanding customer demand.
Organotek Solutions
Our 2 step process has started with addressing the most at risk population via our organotek green intravenous health care solutions. Step 2, includes algae engineered produce and meats. Additionally, Mushroom technology provides a robust immune fortification strategy.
Strategic Partnerships
OWVI, Inc. has a cadre of shareholders and coalition partners in the realm of sports, entertainment, faith and healthcare.
